|
Not yet recruiting
|
NCT05009953 -
Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer
|
Phase 2 |
|
Recruiting
|
NCT05285358 -
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
|
Phase 1 |
|
Recruiting
|
NCT04430738 -
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
|
Phase 1/Phase 2 |
|
Active, not recruiting
|
NCT04853017 -
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
|
Phase 1 |
|
Not yet recruiting
|
NCT05681949 -
Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards
|
N/A |
|
Active, not recruiting
|
NCT02151084 -
A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
|
Phase 2 |
|
Terminated
|
NCT01855724 -
Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer
|
Phase 2 |
|
Withdrawn
|
NCT02105350 -
A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
|
Phase 1 |
|
Recruiting
|
NCT04183712 -
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
|
Phase 2 |
|
Active, not recruiting
|
NCT02834013 -
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
|
Phase 2 |
|
Completed
|
NCT02649712 -
Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction
|
N/A |
|
Recruiting
|
NCT05194072 -
A Study of SGN-B7H4V in Advanced Solid Tumors
|
Phase 1 |
|
Recruiting
|
NCT03581435 -
A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients
|
|
|
Completed
|
NCT03201458 -
Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer
|
Phase 2 |
|
Completed
|
NCT04740164 -
A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP
|
N/A |
|
Completed
|
NCT02333188 -
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer
|
Phase 1 |
|
Recruiting
|
NCT05712356 -
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
|
Phase 2 |
|
Terminated
|
NCT00767234 -
Permission to Collect Blood Over Time for Research
|
N/A |
|
Recruiting
|
NCT03702491 -
Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma
|
Phase 2 |
|
Recruiting
|
NCT04068194 -
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
|
Phase 1/Phase 2 |